ZBTB38 and prostate carcinoma: Interestingly, it was shown that ZBTB38 expression is associated to ROS signalling in cancer cells, suggesting a role of ZBTB38 in the regulation of ROS levels and doxorubicin sensitivity in prostate cancer [32,33].